Prospectively determined impact of type 1 diabetes on brain volume during development

Dana C Perantie, Jonathan M Koller, Patrick M Weaver, Heather M Lugar, Kevin J Black, Neil H White, Tamara Hershey, Dana C Perantie, Jonathan M Koller, Patrick M Weaver, Heather M Lugar, Kevin J Black, Neil H White, Tamara Hershey

Abstract

Objective: The impact of type 1 diabetes mellitus (T1DM) on the developing central nervous system is not well understood. Cross-sectional, retrospective studies suggest that exposure to glycemic extremes during development is harmful to brain structure in youth with T1DM. However, these studies cannot identify brain regions that change differentially over time depending on the degree of exposure to glycemic extremes.

Research design and methods: We performed a longitudinal, prospective structural neuroimaging study of youth with T1DM (n = 75; mean age = 12.5 years) and their nondiabetic siblings (n = 25; mean age = 12.5 years). Each participant was scanned twice, separated by 2 years. Blood glucose control measurements (HbA(1c), glucose meter results, and reports of severe hypoglycemia) were acquired during the 2-year follow-up. Sophisticated image registration algorithms were performed, followed by whole brain and voxel-wise statistical analyses of the change in gray and white matter volume, controlling for age, sex, and age of diabetes onset.

Results: The T1DM and nondiabetic control (NDC) sibling groups did not differ in whole brain or voxel-wise change over the 2-year follow-up. However, within the T1DM group, participants with more hyperglycemia had a greater decrease in whole brain gray matter compared with those with less hyperglycemia (P < 0.05). Participants who experienced severe hypoglycemia had greater decreases in occipital/parietal white matter volume compared with those with no severe hypoglycemia (P < 0.05) and compared with the NDC sibling group (P < 0.05).

Conclusions: These results demonstrate that within diabetes, exposure to hyperglycemia and severe hypoglycemia may result in subtle deviation from normal developmental trajectories of the brain.

Trial registration: ClinicalTrials.gov NCT00879203.

Figures

FIG. 1.
FIG. 1.
Process by which images were prepared for analysis: 1) Unified segment and bias-correction. Images were segmented into gray matter, white matter, and cerebrospinal fluid, and field inhomogeneity-corrected images were produced with SPM8’s “unified segment” module (49). From the next step forward, image preparation steps were performed on gray and white matter segmented images separately. 2) DARTEL import. Gray and white matter segmented images were imported into Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra (DARTEL), a component of SPM8 that determines an average-shaped template from all provided images and calculates high dimensional spatial flow fields between each image and the template (30). During import, images were rigidly aligned and resampled to 1.5 mm cubic voxels. 3) Within-subject DARTEL. For each subject, DARTEL was used to calculate flow fields between Time 1 and Time 2 segmented images and a subject-specific gray or white matter template, which can be considered an image halfway between Time 1 and Time 2. We refer to the within-subject flow fields as “A1” for the warp between Time 1 and subject template and “A2” as the warp between Time 2 and subject template. 4) Between-subject DARTEL. DARTEL was used to calculate flow fields from each subject template to a simultaneously calculated group template, an image representing all 100 subjects. We refer to the warp parameters between subject template and group template as “B.” 5) A 12-parameter affine transformation from the group template to Montreal Neurologic Institute (MNI) template was calculated for ease of interpretation of coordinate results. We refer to the affine transform from group template to MNI space as “C.” 6) Within-subject flow fields (A1 and A2) were applied, respectively, to inhomogeneity-corrected whole brain Time 1 and Time 2 images (produced in Step 1). We averaged the nonzero voxels of the resulting coregistered pair of images. 7) Each subject’s mean image was segmented into gray matter and white matter tissue with SPM8’s unified segment module. 8) A composition of warps from subject template space to MNI space was calculated with SPM’s deformations utility: [subject template to group template] o [group template to MNI], or [B o C]. Composing warps so that they may be applied simultaneously prevents errors that would be introduced by resampling the images multiple times. 9) Composed warps [B o C] were applied to the gray and white matter images produced in Step 7, resulting in segmented images in MNI space. Since the spatial normalization information from subject to MNI space came from the subject-specific template, each time point contributed to the normalization, avoiding potential bias caused by applying normalization parameters of a single time point to both time points. 10) A composition of warps from each time point to MNI space was calculated with the deformations utility: [A1 o B o C] and [A2 o B o C]. 11) The MNI-registered segments were then “modulated” by (multiplied by the Jacobian determinant of) the warps from step 10 to preserve quantitative volume. The influence of independent normalization of each time point was minimized by applying Time 1 and Time 2 Jacobian determinants to the same segments. This resulted in MNI-registered Time 1 and Time 2 gray and white matter segmented images whose intensities correspond to units of volume. 12) MNI-registered Time 1 and Time 2 images were smoothed with a Gaussian kernel 8-mm full-width at half-maximum. 13) Time 1 segment images were subtracted from Time 2 segment images to create images representing change in gray or white matter volume over time. These different images were entered into statistical models to relate brain volume changes over time to variables of interest such as hypoglycemia and hyperglycemia exposure. ImCalc, image calculator.
FIG. 2.
FIG. 2.
A: Mean ± SEM percent change in whole brain gray matter across hyperglycemia subgroups and NDCs. *Different from other HbA1c groups (P < 0.05) and marginally different from NDC (P = 0.06). B: Occipital/parietal white matter across severe hypoglycemia subgroups and NDCs. *Different from other groups (P < 0.05). C: Statistical image showing occipital/parietal region where T1DM with any hypoglycemia differ from T1DM with no hypoglycemia. Hypo, hypoglycemia. (A high-quality digital representation of this figure is available in the online issue.)

References

    1. Olsen BS, Sjølie A, Hougaard P, et al. . A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. J Diabetes Complications 2000;14:295–300
    1. Chkhartishvili D, Khachapuridze N, Natriashvili G, Geladze N, Kapanadze N. Nerve conduction abnormalities in children with type I diabetes. Annals of Biomedical Research and Education 2002;2:331–334
    1. Riihimaa PH, Suominen K, Tolonen U, Jäntti V, Knip M, Tapanainen P. Peripheral nerve function is increasingly impaired during puberty in adolescents with type 1 diabetes. Diabetes Care 2001;24:1087–1092
    1. Northam EA, Rankins D, Lin A, et al. . Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009;32:445–450
    1. Perantie DC, Wu J, Koller JM, et al. . Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007;30:2331–2337
    1. Ho MS, Weller NJ, Ives FJ, et al. . Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus. J Pediatr 2008;153:385–390
    1. Di Marzio D, Mohn A, Mokini ZH, Giannini C, Chiarelli F. Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1). Horm Metab Res 2006;38:691–705
    1. Folli F, Guzzi V, Perego L, et al. . Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients’ skin which are normalized by kidney-pancreas transplantation. PLoS ONE 2010;5:e9923.
    1. Rask-Madsen C, King GL. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 2007;3:46–56
    1. Wessels AM, Simsek S, Remijnse PL, et al. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006;49:2474–2480
    1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–820
    1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615–1625
    1. Vlassara H, Brownlee M, Cerami A. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 1983;32:670–674
    1. Auer RN, Siesjö BK. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 1988;24:699–707
    1. Auer RN, Olsson Y, Siesjö BK. Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study. Diabetes 1984;33:1090–1098
    1. Auer RN, Hugh J, Cosgrove E, Curry B. Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol 1989;8:63–68
    1. Fujioka M, Okuchi K, Hiramatsu KI, Sakaki T, Sakaguchi S, Ishii Y. Specific changes in human brain after hypoglycemic injury. Stroke 1997;28:584–587
    1. Kalimo H, Olsson Y. Effects of severe hypoglycemia on the human brain. Neuropathological case reports. Acta Neurol Scand 1980;62:345–356
    1. Sieber FE, Traystman RJ. Special issues: glucose and the brain. Crit Care Med 1992;20:104–114
    1. McCall AL. The impact of diabetes on the CNS. Diabetes 1992;41:557–570
    1. Wieloch T. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 1985;230:681–683
    1. Ouyang YB, He QP, Li PA, Janelidze S, Wang GX, Siesjö BK. Is neuronal injury caused by hypoglycemic coma of the necrotic or apoptotic type? Neurochem Res 2000;25:661–667
    1. Yamada KA, Rensing N, Izumi Y, et al. . Repetitive hypoglycemia in young rats impairs hippocampal long-term potentiation. Pediatr Res 2004;55:372–379
    1. Ennis K, Tran PV, Seaquist ER, Rao R. Postnatal age influences hypoglycemia-induced neuronal injury in the rat brain. Brain Res 2008;1224:119–126
    1. Thompson PM, Sowell ER, Gogtay N, et al. . Structural MRI and brain development. Int Rev Neurobiol 2005;67:285–323
    1. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97–113
    1. The DCCT Research Group . Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991;90:450–459
    1. Black KJ, Snyder AZ, Koller JM, Gado MH, Perlmutter JS. Template images for nonhuman primate neuroimaging: 1. Baboon. Neuroimage 2001;14:736–743
    1. Kipps CM, Duggins AJ, Mahant N, Gomes L, Ashburner J, McCusker EA. Progression of structural neuropathology in preclinical Huntington’s disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry 2005;76:650–655
    1. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95–113
    1. Ashburner J, Friston KJ. Voxel-based morphometry—the methods. Neuroimage 2000;11:805–821
    1. Worsley KJ, Liao CH, Aston J, et al. . A general statistical analysis for fMRI data. Neuroimage 2002;15:1–15
    1. Moorhead TW, Job DE, Spencer MD, Whalley HC, Johnstone EC, Lawrie SM. Empirical comparison of maximal voxel and non-isotropic adjusted cluster extent results in a voxel-based morphometry study of comorbid learning disability with schizophrenia. Neuroimage 2005;28:544–552
    1. Northam EA, Anderson PJ, Werther GA, Warne GL, Adler RG, Andrewes D. Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 1998;21:379–384
    1. Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Werther GA. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001;24:1541–1546
    1. Hershey T, Perantie DC, Warren SL, Zimmerman EC, Sadler M, White NH. Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care 2005;28:2372–2377
    1. Ferguson SC, Blane A, Perros P, et al. . Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003;52:149–156
    1. Ferguson SC, Blane A, Wardlaw J, et al. . Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 2005;28:1431–1437
    1. Lobnig BM, Krömeke O, Optenhostert-Porst C, Wolf OT. Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diabet Med 2006;23:32–39
    1. Karimzadeh P, Tabarestani S, Ghofrani M. Hypoglycemia-occipital syndrome: a specific neurologic syndrome following neonatal hypoglycemia? J Child Neurol 2010;26:152–159
    1. Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 2008;122:65–74
    1. Barkovich AJ, Ali FA, Rowley HA, Bass N. Imaging patterns of neonatal hypoglycemia. AJNR Am J Neuroradiol 1998;19:523–528
    1. Kodl CT, Franc DT, Rao JP, et al. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 2008;57:3083–3089
    1. Yan H, Rivkees SA. Hypoglycemia influences oligodendrocyte development and myelin formation. Neuroreport 2006;17:55–59
    1. Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain 2006;129:564–583
    1. Vincent JL, Snyder AZ, Fox MD, et al. . Coherent spontaneous activity identifies a hippocampal-parietal memory network. J Neurophysiol 2006;96:3517–3531
    1. Blasetti A, Chiuri RM, Tocco AM, et al. The effect of recurrent severe hypoglycemia on cognitive performance in children with type 1 diabetes: a meta-analysis. J Child Neurol. 13 May 2011 [Epub ahead of print]
    1. Naguib JM, Kulinskaya E, Lomax CL, Garralda ME. Neuro-cognitive performance in children with type 1 diabetes: a meta-analysis. J Pediatr Psychol 2008;34:271–282
    1. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839–851

Source: PubMed

3
Sottoscrivi